Wednesday, April 20, 2016

Genmab raises 2016 guidance on strong Darzalex sales

COPENHAGEN, April 20 (Reuters) - Danish biotech company

Genmab raised its financial guidance for 2016 on

Wednesday due to "robust" sales of its blood cancer drug

Darzalex since it was launched in...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)